Skip to main content
Erschienen in: Annals of Surgical Oncology 1/2023

26.08.2022 | Thoracic Oncology

Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative

verfasst von: Sidra N. Bonner, MD, MPH, MSc, Chang He, MS, Melissa Clark, MSN, RN, Kumari Adams, MD, Felix Orelaru, MD, Andrew Popoff, MD, Andrew Chang, MD, Elliot Wakeam, MD, MPH, Kiran Lagisetty, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Persistent racial disparities in lung cancer incidence, treatment, and survival are well documented. Given the importance of surgical resection for lung cancer treatment, racial disparities in surgical quality were investigated using a statewide quality collaborative.

Methods

This retrospective study used data from the Michigan Society of Cardiothoracic Surgeons General Thoracic database, which includes data gathered for the Society of Thoracic Surgeons General Thoracic Surgery Database at 17 institutions in Michigan. Adult patients undergoing resection for lung cancer between 2015 and 2021 were included. Propensity score-weighting methodology was used to assess differences in surgical quality, including extent of resection, adequate lymph node evaluation, 30-day mortality, and 30-day readmission rate between white and black patients.

Results

The cohort included 5073 patients comprising 357 (7%) black and 4716 (93%) white patients. The black patients had significantly higher unadjusted rates of wedge resection than the white patients, but after propensity score-weighting for clinical factors, wedge resection did not differ from lobectomy (odds ratio [OR], 1.07; 95% confidence interval [CI], 0.78–1.49; P = 0.67). The black patients had fewer lymph nodes collected (incidence rate ratio [IRR], 0.77; 95% CI, 0.73–0.81; P < 0.0001) and lymph node stations sampled (IRR, 0.89; 95% CI, 0.84–0.94; P < 0.0001). The black patients did not differ from the white patients in terms of mortality (OR, 0.65; 95% CI, 0.19–2.34; P = 0.55) or readmission (OR, 0.79; 95 % CI, 0.49–1.27; P = 0.32). The black patients had longer hospital stays (OR, 1.08; 95% CI, 1.02–1.14; P = 0.01).

Conclusion

In a statewide quality collaborative that included high-volume centers, black patients received a less extensive lymph node evaluation, with fewer non-anatomic wedge resections performed, and a more limited lymph node evaluation with lobectomy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198–205.CrossRef Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198–205.CrossRef
5.
Zurück zum Zitat Lam MB, Raphael K, Mehtsun WT, et al. Changes in racial disparities in mortality after cancer surgery in the US, 2007–2016. JAMA Netw Open. 2020;3:e2027415.CrossRef Lam MB, Raphael K, Mehtsun WT, et al. Changes in racial disparities in mortality after cancer surgery in the US, 2007–2016. JAMA Netw Open. 2020;3:e2027415.CrossRef
6.
Zurück zum Zitat Alwatari Y, Sabra MJ, Khoraki J, Ayalew D, Wolfe LG, Cassano AD, Shah RD. Does race or ethnicity impact complications after pulmonary lobectomy for patients with lung cancer? J Surg Res. 2021;262:165–74.CrossRef Alwatari Y, Sabra MJ, Khoraki J, Ayalew D, Wolfe LG, Cassano AD, Shah RD. Does race or ethnicity impact complications after pulmonary lobectomy for patients with lung cancer? J Surg Res. 2021;262:165–74.CrossRef
7.
Zurück zum Zitat Parsons HM, Habermann EB, Stain SC, Vickers SN, Al-Refaie WB. What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons National Surgical Quality Improvement Program Hospitals? JACS. 2012;2012(214):539–47. Parsons HM, Habermann EB, Stain SC, Vickers SN, Al-Refaie WB. What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons National Surgical Quality Improvement Program Hospitals? JACS. 2012;2012(214):539–47.
8.
Zurück zum Zitat Gee GC, Ford CL. Structural racism and health inequities: old issues, new directions. Du Bois Rev. 2011;8:115–32.CrossRef Gee GC, Ford CL. Structural racism and health inequities: old issues, new directions. Du Bois Rev. 2011;8:115–32.CrossRef
9.
Zurück zum Zitat Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389:1453–63.CrossRef Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389:1453–63.CrossRef
10.
Zurück zum Zitat Lathan CS, Neville BA, Earle CC. Racial composition of hospitals: effects on surgery for early-stage non-small cell lung cancer. J Clin Oncol. 2016;26:4347–52.CrossRef Lathan CS, Neville BA, Earle CC. Racial composition of hospitals: effects on surgery for early-stage non-small cell lung cancer. J Clin Oncol. 2016;26:4347–52.CrossRef
11.
Zurück zum Zitat Dimick J, Ruhter J, Sarrazin MV, Birkmeyer JD. Black patients more likely than whites to undergo surgery at low-quality hospitals in segregated regions. Health Aff Millwood. 2013;32:1046–53.CrossRef Dimick J, Ruhter J, Sarrazin MV, Birkmeyer JD. Black patients more likely than whites to undergo surgery at low-quality hospitals in segregated regions. Health Aff Millwood. 2013;32:1046–53.CrossRef
12.
Zurück zum Zitat Hayanga AJ, Zeliadt SB, Backhus LM. Residential segregation and lung cancer mortality in the United States. JAMA Surg. 2013;148:37–42.CrossRef Hayanga AJ, Zeliadt SB, Backhus LM. Residential segregation and lung cancer mortality in the United States. JAMA Surg. 2013;148:37–42.CrossRef
13.
Zurück zum Zitat Annesi CA, Poulson MR, Mak KS, et al. The impact of residential racial segregation on non-small cell lung cancer treatment and outcomes. Ann Thorac Surg. 2022;113(4):1291–1298.CrossRef Annesi CA, Poulson MR, Mak KS, et al. The impact of residential racial segregation on non-small cell lung cancer treatment and outcomes. Ann Thorac Surg. 2022;113(4):1291–1298.CrossRef
14.
Zurück zum Zitat Farjah F, Wood DE, Yanez ND III, et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg. 2009;144:14–8.CrossRef Farjah F, Wood DE, Yanez ND III, et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg. 2009;144:14–8.CrossRef
15.
Zurück zum Zitat Cykert S, Dilworth-Anderson P, Monroe MH, et al. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA. 2010;303:2368–76.CrossRef Cykert S, Dilworth-Anderson P, Monroe MH, et al. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA. 2010;303:2368–76.CrossRef
16.
Zurück zum Zitat Suga JM, et al. Racial disparities on the use of invasive and non-invasive stating in patients with non-small cell lung cancer. J Thorac Oncol. 2010;5:1772–8.CrossRef Suga JM, et al. Racial disparities on the use of invasive and non-invasive stating in patients with non-small cell lung cancer. J Thorac Oncol. 2010;5:1772–8.CrossRef
18.
Zurück zum Zitat Le Cook B, McGuire TG, Zaslavksy AM. Measuring racial/ethnic disparities in healthcare: methods and practical issues. Health Serv Res. 2012;47(3 Pt 2):1232–54.CrossRef Le Cook B, McGuire TG, Zaslavksy AM. Measuring racial/ethnic disparities in healthcare: methods and practical issues. Health Serv Res. 2012;47(3 Pt 2):1232–54.CrossRef
19.
Zurück zum Zitat Taioli E, Liu B, Nicastri DG, Liberman-Cribbin W, Leoncini E, Flores RM. Personal and hospital factors associated with limited surgical resection for lung cancer, in-hospital mortality, and complications in New York State. J Surg Oncol. 2017;116:471–81.CrossRef Taioli E, Liu B, Nicastri DG, Liberman-Cribbin W, Leoncini E, Flores RM. Personal and hospital factors associated with limited surgical resection for lung cancer, in-hospital mortality, and complications in New York State. J Surg Oncol. 2017;116:471–81.CrossRef
20.
Zurück zum Zitat Osarogiagbon RU, Ogbata O, Yu X. Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. Ann Thorac Surg. 2014;97:385–93.CrossRef Osarogiagbon RU, Ogbata O, Yu X. Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. Ann Thorac Surg. 2014;97:385–93.CrossRef
21.
Zurück zum Zitat Pennathur A, Brunelli A, Criner GJ, et al. Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: the American association for thoracic surgery expert panel consensus document. AATS clinical practice standards committee: Thoracic Surgery. J Thorac Cardiovasc Surg. 2021;162:1605–18.CrossRef Pennathur A, Brunelli A, Criner GJ, et al. Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: the American association for thoracic surgery expert panel consensus document. AATS clinical practice standards committee: Thoracic Surgery. J Thorac Cardiovasc Surg. 2021;162:1605–18.CrossRef
22.
Zurück zum Zitat Williams CD, Stechuchak KM, Zullig LL, Provenzale D, Kelley MJ. Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small cell lung cancer. J Clin Oncol. 2013;31:475–81.CrossRef Williams CD, Stechuchak KM, Zullig LL, Provenzale D, Kelley MJ. Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small cell lung cancer. J Clin Oncol. 2013;31:475–81.CrossRef
23.
Zurück zum Zitat Ferguson MK, Demchuk C, Wroblewski K, et al. Does race influence risk assessment and recommendations for lung resection? A randomized trial. Ann Thorac Surg. 2018;106:1013–7.CrossRef Ferguson MK, Demchuk C, Wroblewski K, et al. Does race influence risk assessment and recommendations for lung resection? A randomized trial. Ann Thorac Surg. 2018;106:1013–7.CrossRef
24.
Zurück zum Zitat Allen MS, Harmsen WS, Mandrekar J, Rocco G. Bias against complex lung cancer surgery. Ann Thorac Surg. 2021;112:1824–31.CrossRef Allen MS, Harmsen WS, Mandrekar J, Rocco G. Bias against complex lung cancer surgery. Ann Thorac Surg. 2021;112:1824–31.CrossRef
25.
Zurück zum Zitat Shaffer R, Backhus L, Finnegann MA, et al. Thirty-day unplanned postoperative inpatient and emergency department visits following thoracotomy. J Surg Res. 2018;230:117–24.CrossRef Shaffer R, Backhus L, Finnegann MA, et al. Thirty-day unplanned postoperative inpatient and emergency department visits following thoracotomy. J Surg Res. 2018;230:117–24.CrossRef
26.
Zurück zum Zitat Tong BC, Kim S, Kosinksi A, et al. Penetration, completeness, and representativeness of The Society of Thoracic Surgeons General Thoracic Surgery Database for Lobectomy. Ann Thorac Surg. 2019;107:897–902.CrossRef Tong BC, Kim S, Kosinksi A, et al. Penetration, completeness, and representativeness of The Society of Thoracic Surgeons General Thoracic Surgery Database for Lobectomy. Ann Thorac Surg. 2019;107:897–902.CrossRef
27.
Zurück zum Zitat Epstein AJ, Gray BH, Schlesinger M. Racial and ethnic differences in the use of high-volume hospitals and surgeons. Arch Surg. 2010;145:179–86.CrossRef Epstein AJ, Gray BH, Schlesinger M. Racial and ethnic differences in the use of high-volume hospitals and surgeons. Arch Surg. 2010;145:179–86.CrossRef
28.
Zurück zum Zitat Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The Influence of hospital volume on survival after resection for lung cancer. N Eng J Med. 2001;345:181–8.CrossRef Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The Influence of hospital volume on survival after resection for lung cancer. N Eng J Med. 2001;345:181–8.CrossRef
29.
Zurück zum Zitat von Meyenfeldt EM, Gooiker GA, van Gjin W, et al. The relationship between volume or surgeon specialty and outcome in the surgical treatment of lung cancer: a systematic review and meta-analysis. J Thorac Oncol. 2012;7:1170–8.CrossRef von Meyenfeldt EM, Gooiker GA, van Gjin W, et al. The relationship between volume or surgeon specialty and outcome in the surgical treatment of lung cancer: a systematic review and meta-analysis. J Thorac Oncol. 2012;7:1170–8.CrossRef
30.
Zurück zum Zitat Fernandez FG, Kosinski AS, Burfeing W, et al. The Society of Thoracic Surgeons lung cancer resection risk model: higher quality data and superior outcomes [published correction appears in Ann Thorac Surg. 2017;104:726]. Ann Thorac Surg. 2016;102:370–7.CrossRef Fernandez FG, Kosinski AS, Burfeing W, et al. The Society of Thoracic Surgeons lung cancer resection risk model: higher quality data and superior outcomes [published correction appears in Ann Thorac Surg. 2017;104:726]. Ann Thorac Surg. 2016;102:370–7.CrossRef
31.
Zurück zum Zitat Batchelor TJP, Rashburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg. 2019;55:91–115.CrossRef Batchelor TJP, Rashburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg. 2019;55:91–115.CrossRef
32.
Zurück zum Zitat Sanchez-Lorente D, Navarro-Ripoll R, Guzman R, et al. Prehabilitation in thoracic surgery. J Thorac Dis. 2018;10(Suppl 22):S2593–600.CrossRef Sanchez-Lorente D, Navarro-Ripoll R, Guzman R, et al. Prehabilitation in thoracic surgery. J Thorac Dis. 2018;10(Suppl 22):S2593–600.CrossRef
33.
Zurück zum Zitat Chandra A, Frankes M, Malani A. Challenges to reducing discrimination and health inequity through existing civil rights laws. Health Aff. 2017;36:1041–7.CrossRef Chandra A, Frankes M, Malani A. Challenges to reducing discrimination and health inequity through existing civil rights laws. Health Aff. 2017;36:1041–7.CrossRef
Metadaten
Titel
Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative
verfasst von
Sidra N. Bonner, MD, MPH, MSc
Chang He, MS
Melissa Clark, MSN, RN
Kumari Adams, MD
Felix Orelaru, MD
Andrew Popoff, MD
Andrew Chang, MD
Elliot Wakeam, MD, MPH
Kiran Lagisetty, MD
Publikationsdatum
26.08.2022
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2023
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-022-12435-x

Weitere Artikel der Ausgabe 1/2023

Annals of Surgical Oncology 1/2023 Zur Ausgabe

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.